JustChartThings

PIRS on the way to recovery?

Pembelian
NASDAQ:PIRS   Pieris Pharmaceuticals, Inc.
First close above the EMA10 in 20 trading days, when stocks began tumbling in January. In at 1.57 last week, looking for a continuation closing above the EMA10 on Monday. Recent MACD cross and OBV increase support the continuation; RSI cross above 50 and we may see a return to the MA50 in the near term. PIRS seems like a good long-term value play here, but taking profits at appropriate times seems like the best thing to do in the current market unless you have a lot of flexibility.
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.